Which drugs does patent 8,722,084 protect, and when does it expire?
Patent 8,722,084 protects DEXILANT and is included in one NDA. There have been two Paragraph IV challenges on Dexilant.
Protection for DEXILANT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty patent family members in twenty-eight countries.